circICMT upregulates and suppresses the malignant behavior of bladder cancer

Xin Luo1, FangMei Xie2, Guoqiang Qin1

  • 1Department of Urology, The Affiliated Panyu Central Hospital, Guangzhou Medical University, Guangzhou, Guangdong 511400, PR China.

Translational Oncology
|December 29, 2024
PubMed
Abstract

Insights

Circular RNA Intron-Containing Methyltransferase (circICMT) is highly expressed in bladder cancer and inhibits tumor progression. Modulating circICMT affects cancer cell behavior, suggesting its potential as a biomarker and therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Circular RNAs (circRNAs) are novel RNA molecules regulating gene expression in cancers.
  • circICMT, derived from the ICMT gene, has an unclear role in bladder cancer.
  • Understanding circICMT's function is crucial for bladder cancer research.

Purpose of the Study:

  • To investigate the role and molecular function of circICMT in bladder cancer.
  • To determine if circICMT expression levels correlate with bladder cancer progression.
  • To explore circICMT as a potential therapeutic target.

Main Methods:

  • RNA sequencing identified differentially expressed circRNAs, including circICMT.
  • Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and Sanger sequencing validated circICMT expression in tumor tissues.
  • Cellular assays (wound healing, colony formation, CCK-8) and xenograft models assessed circICMT's functional impact.

Main Results:

  • circICMT was significantly upregulated in bladder cancer tissues.
  • Overexpression of circICMT suppressed bladder cancer cell migration, proliferation, and colony formation.
  • Knockdown of circICMT promoted the malignant phenotype of bladder cancer cells.
  • Bioinformatics analysis suggested circICMT interacts with microRNAs and RNA-binding proteins, forming a regulatory network.

Conclusions:

  • circICMT is highly expressed in bladder cancer and influences its malignant phenotype.
  • Intervention of circICMT expression impacts bladder cancer cell behavior both in vitro and in vivo.
  • circICMT represents a promising biomarker and therapeutic target for bladder cancer management.